Inventiva (IVA) Receivables - Net (2018 - 2025)
Inventiva (IVA) recorded quarterly Receivables - Net of $2.3 million in Q4 2025, down 99.98% quarter-over-quarter from $12.2 billion in Q2 2025, and up 313.57% on a YoY basis from $567424.2 in Q4 2024.
Inventiva (IVA) Receivables - Net (2018 - 2025) Analysis & Trends
Inventiva's Receivables - Net history runs 8 years deep, the most recent figure standing at $2.3 million for Q4 2025.
- In Q4 2025, Receivables - Net rose 313.57% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $2.3 million (up 313.57% YoY), while the FY2025 annual figure was $2.3 million, up 313.57% from the prior year.
- Receivables - Net was $2.3 million for Q4 2025 at Inventiva, down from $12.2 billion in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $12.2 billion in Q2 2025 to a low of $1206.2 in Q1 2021.
- Historically, Receivables - Net has averaged $1.2 billion across 5 years, with a median of $2.4 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net sank 86.15% in 2024, then surged 297101.78% in 2025.
- A 5-year view of Receivables - Net shows it stood at $4.6 million in 2021, then plunged by 76.68% to $1.1 million in 2022, then surged by 283.87% to $4.1 million in 2023, then plunged by 86.15% to $567424.2 in 2024, then surged by 313.57% to $2.3 million in 2025.
- The last three Receivables - Net figures came in at $2.3 million (Q4 2025), $12.2 billion (Q2 2025), and $567424.2 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.35 Mn |
| Dec 31, 2025 | 2.35 Mn |
| Jun 30, 2025 | 12.18 Bn |
| Jun 30, 2025 | 12.18 Bn |
| Dec 31, 2024 | 567,424.16 |
| Dec 31, 2024 | 567,424.16 |
| Jun 30, 2024 | 4.10 Mn |
| Jun 30, 2024 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Dec 31, 2023 | 4.10 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 2.42 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Jun 30, 2021 | 8,429.90 |
| Jun 30, 2021 | 8,429.90 |
| Mar 31, 2021 | 1,206.24 |
| Mar 31, 2021 | 1,206.24 |